Short Report

You have full text access to this OnlineOpen article

Modulation by budesonide of DNA methylation and mRNA expression in mouse lung tumors

  1. Michael A. Pereira1,†,*,
  2. Lianhui Tao1,
  3. Yue Liu1,
  4. Long Li1,
  5. Vernon E. Steele2,
  6. Ronald A. Lubet2

Article first published online: 12 DEC 2006

DOI: 10.1002/ijc.22468

Issue

International Journal of Cancer

International Journal of Cancer

Volume 120, Issue 5, pages 1150–1153, 1 March 2007

Additional Information

How to Cite

Pereira, M. A., Tao, L., Liu, Y., Li, L., Steele, V. E. and Lubet, R. A. (2007), Modulation by budesonide of DNA methylation and mRNA expression in mouse lung tumors. Int. J. Cancer, 120: 1150–1153. doi: 10.1002/ijc.22468

Author Information

  1. 1

    Division of Hematology and Oncology, Ohio State University, College of Medicine, Columbus, OH

  2. 2

    Chemopreventive Agent Development Research Group, National Cancer Institute, Bethesda, MD

  1. †

    Fax: +614-293-4072.

*Ohio State University, College of Medicine and Public Health, Department of Internal Medicine, 300 West Tenth Avenue, 1148 CHRI, Columbus, OH 43210, USA

Publication History

  1. Issue published online: 19 JAN 2007
  2. Article first published online: 12 DEC 2006
  3. Manuscript Accepted: 11 OCT 2006
  4. Manuscript Received: 20 JUN 2006

Funded by

  • U.S. National Cancer Institute. Grant Numbers: N01-CN-15125, 25126

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (80K)

References

  • 1
    Banov CH. The role of budesonide in adults and children with mild-to-moderate persistent asthma. J Asthma 2004; 41: 5–17.
  • 2
    Wattenberg LW, Wiedmann TS, Estensen RD, Zimmerman CL, Steele VE, Kelloff GJ. Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res 1197; 57: 5489–92.
  • 3
    Wattenberg LW, Wiedmann TS, Estensen RD, Zimmerman CL, Galbraith AR, Steele VE, Kelloff GJ. Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol. Carcinogenesis 2000; 21: 179–82.
  • 4
    Pereira MA, Li Y, Gunning WT, Kramer PM, Alyaqoub FS, Lubet RA, Steele VE, Szabo E, Tao L. Prevention of mouse lung tumors by budesonide and its modulation of biomarkers. Carcinogenesis 2002; 23: 1185–92.
  • 5
    Pereira MA, Tao LH, Wang W, Gunning WTY, Lubet RA. Chemoprevention: mouse colon and lung tumor bioassay and modulation of DNA methylation as a biomarker. Exp Lung Res 2005; 31: 155–63.
  • 6
    Wang Y, Zhang Z, Kastens E, Lubet RA, You M. Mice with alteration in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice. Cancer Res 2003; 63: 4389–95.
  • 7
    Estensen RD, Jordan MM, Wiedmann TS, Galbraith AR, Steele VE, Wattenberg LW. Effect of chemopreventive agents on separate stages of progression of benzo[ α]pyrene induced lung tumors in A/J mice. Carcinogenesis 2004; 25: 197–201.
  • 8
    Yao R, Wang Y, Lemon WJ, Lubet RA, You M. Budesonide exerts its chemopreventive efficacy during mouse lung tumorigenesis by modulating gene expressions. Oncogene 2004; 23: 7746–52.
  • 9
    Alyaqoub FS, Tao L, Kramer PM, Steele VE, Lubet LA, Gunning WT, Pereira MA. Prevention of mouse lung tumors and modulation of DNA methylation by combined treatment with budesonide and R115777 (Zarnestra™). Carcinogenesis, in press.
  • 10
    Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 2000; 25: 402–8.
  • 11
    Liu Y, Alyaqoub FS, Tao L, Steele VE, Lubet RA, Pereira MA. Effect of long- and short-term treatment with targretin on DNA methylation and mRNA expression in vinyl carbamate-induced mouse lung tumors. Fourth Ann Frontiers Cancer Prev Res 2005; 166.
  • 12
    Dunn BK. Hypomethylation: one side of a larger picture. Ann NY Acad Sci 2003; 983: 28–42.
    Direct Link:
  • 13
    Cui H, Onyango P, Brandenburg S, Wu Y, Hsieh C-L, Feinberg AP. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res 2002; 62: 6442–6.
  • 14
    Esfandiari F, Green R, Cotterman RF, Pogribny IP, James SJ, Miller JW. Methyl deficiency causes reduction of the methyl-CpG-binding protein, MeCP2, in rat liver. Carcinogenesis 2003; 24: 1935–40.
  • 15
    Jackson M, Krassowska A, Gilbert N, Chevassut T, Forrester L, Ansell J, Ramsahoye B. Severe global DNA hypomethylation blocks differentiation and induces histone hyperacetylation in embryonic stem cells. Mol Cell Biol 2004; 24: 8862–71.
  • 16
    Gilbert J, Gore SD, Herman JG, Carducci MA. The clinical application of targeting cancer through histone acetylation and hypomethylation. Clin Cancer Res 2004; 10: 4589–96.
  • 17
    Feinberg AP, Cui H, Ohlsson R. DNA methylation and genomic imprinting: insights from cancer into epigenetic mechanisms. Semin Cancer Biol 2002; 12: 389–98.
View Full Article (HTML) Get PDF (80K)